FDA Inspection 1162864 — Viatris Pharmaceuticals LLC

Viatris Pharmaceuticals LLC — FEI 2623619

The FDA completed an inspection of Viatris Pharmaceuticals LLC on February 17, 2022 in Vega Baja, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vega Baja, PR (United States)

Citations

IDCFRDescription
188321 CFR 211.165(a)Testing and release for distribution